×

Sign In

Search
Home

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

By Thomson Reuters Mar 23, 2026 | 5:27 PM

March 23 (Reuters) – Gilead ‌Sciences said ‌on Monday ⁠it would ⁠buy privately held ⁠biotech ⁠firm Ouro Medicines in a ‌deal ⁠worth up to $2.18 ⁠billion.

(Reporting ‌by ⁠Mariam Sunny ‌in Bengaluru; Editing ⁠by Shilpi Majumdar)

NTSB probes controller as part of broader investigation into LaGuardia airport collision

Japan's core inflation slows below BOJ target, complicates rate path

At least 34 killed in Colombia military plane crash, governor says

Japan Feb core CPI rises 1.6% yr/yr

About 300 protesters chant, rally outside energy conference

Brazil finance minister taps Ceron for executive secretary, Leal to Treasury

Privacy Policy
Terms Of Service

Copyright © 2026. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.